Baylor University Medical Center Proceedings January 2014, Volume 27, Number 1 | Page 76

short-term support devices and ECMO achieved comparable results.
In the modern era of medical cost restraints, ECMO may be more
cost effective for patients with postinfarction- or decompensated
cardiomyopathy-related cardiogenic shock. Larger randomized trials
may be necessary to further elucidate this topic.

CELLULAR IMMUNOLOGY
CD11b+ cells in donor-specific transfusion prolonged allogenic
skin graft survival through indoleamine